Latest filing published 01 Oct 2026 for CERENOME, INC..
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -86.9%Entry US$55.25 · Close at T+365 US$7.25
- -27.2%Entry US$50.50 · Close at T+365 US$36.75
- -45.0%Entry US$100.50 · Close at T+365 US$55.25
- -75.1%Entry US$202.50 · Close at T+365 US$50.50
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Howard Clowes: trading record in brief
Howard Clowes (board member) discloses dealings in Cerenome, Inc. to SEC (Form 4). Over a trading history stretching from 3 March 2021 to 1 October 2026, the count stands at 9 filings.
On the market, this insider has only ever bought: 7 purchases, €60k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 2 option exercises.
Half of the purchases are above €7,989 and half below. Of 7 purchases, 4 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster. Ninety days after publication, 4 purchases show a median change of -32.1%, with the price up in 0% of them. These figures describe past trades and do not predict future prices.
The newest entry dates from 1 October 2026: an option exercise, in Cerenome, Inc. The last insider purchase was made public on 13 September 2024, 787 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Howard Clowes
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 921 shares0Common StockSEC:0001193125-26-409860:0
- 922 sharesCommon StockSEC:0001193125-26-292639:0
- 5,000 shares@ US$1.336211.2% of flowCommon StockSEC:0000950170-24-106179:0Canonical exit: 10 Dec 2024 (T+90)
- 9,804 shares@ US$2.0434.5% of flowCommon StockSEC:0000950170-24-057452:0Canonical exit: 6 Aug 2024 (T+90)
- 6,993 shares@ US$1.433117.3% of flowCommon StockSEC:0001209191-23-049535:0Canonical exit: 12 Dec 2023 (T+90)
- 1,000 shares@ US$3.986.9% of flowCommon StockSEC:0001209191-23-035267:0Canonical exit: 4 Sept 2023 (T+90)
- 2,500 shares@ US$3.640615.2% of flowCommon StockSEC:0001209191-23-027213:0Canonical exit: 1 Aug 2023 (T+90)
- 15,000 shares@ US$0.572614.8% of flowCommon StockSEC:0001209191-22-034420:0Canonical exit: 31 Aug 2022 (T+90)
8 of 8 declarations
